Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1988 Oct;64(756):735–742. doi: 10.1136/pgmj.64.756.735

The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis.

H C Ford 1, J M Carter 1
PMCID: PMC2429012  PMID: 3076660

Abstract

The abnormalities of erythrocytes, leucocytes, thrombocytes and coagulation that have been reported, particularly in more recent years, to be associated with hyperthyroidism are surveyed. Several areas are highlighted where further investigations could lead to clinically useful insights, improved information about the haematological processes involved or to a better understanding of thyroid hormone action.

Full text

PDF
735

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AXELROD A. R., BERMAN L. The bone marrow in hyperthyroidism and hypothyroidism. Blood. 1951 May;6(5):436–453. [PubMed] [Google Scholar]
  2. Adrouny A., Sandler R. M., Carmel R. Variable presentation of thrombocytopenia in Graves' disease. Arch Intern Med. 1982 Aug;142(8):1460–1464. [PubMed] [Google Scholar]
  3. Alvarez-Sala J. L., Urbán M. A., Sicilia J. J., Diaz Fdez A. J., Fdez Mendieta F., Espinós D. Red-cell 2,3-diphosphoglycerate in patients with hyperthryoidism. Acta Endocrinol (Copenh) 1980 Apr;93(4):424–429. doi: 10.1530/acta.0.0930424. [DOI] [PubMed] [Google Scholar]
  4. Anker N., Mondrup M. Carbonic anhydrase isoenzyme B in erythrocytes of subjects with thyroid disorders. Clin Chim Acta. 1974 Aug 20;54(3):277–282. doi: 10.1016/0009-8981(74)90246-0. [DOI] [PubMed] [Google Scholar]
  5. BOEKELMAN W. A. Sodium content of erythrocytes in hyperthyroidism. Nature. 1958 Apr 19;181(4616):1136–1136. doi: 10.1038/1811136a0. [DOI] [PubMed] [Google Scholar]
  6. Benesch R., Benesch R. E. The effect of organic phosphates from the human erythrocyte on the allosteric properties of hemoglobin. Biochem Biophys Res Commun. 1967 Jan 23;26(2):162–167. doi: 10.1016/0006-291x(67)90228-8. [DOI] [PubMed] [Google Scholar]
  7. Bremner W. F., Fell G. S. Zinc metabolism and thyroid status. Postgrad Med J. 1977 Mar;53(617):143–145. doi: 10.1136/pgmj.53.617.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Buse J. B., Eisenbarth G. S. Autoimmune endocrine disease. Vitam Horm. 1985;42:253–314. doi: 10.1016/s0083-6729(08)60064-3. [DOI] [PubMed] [Google Scholar]
  9. Chan J. Y., Walfish P. G. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry. J Clin Endocrinol Metab. 1986 Feb;62(2):403–409. doi: 10.1210/jcem-62-2-403. [DOI] [PubMed] [Google Scholar]
  10. Chanutin A., Curnish R. R. Effect of organic and inorganic phosphates on the oxygen equilibrium of human erythrocytes. Arch Biochem Biophys. 1967 Jul;121(1):96–102. doi: 10.1016/0003-9861(67)90013-6. [DOI] [PubMed] [Google Scholar]
  11. Cohen J., Somma-Delpero C., Verine A., Codaccioni J. L., Boyer J. Increased monoester lipase activity in red blood cells during hyperthyroidism. J Endocrinol. 1986 Mar;108(3):357–359. doi: 10.1677/joe.0.1080357. [DOI] [PubMed] [Google Scholar]
  12. Cole C. H., Waddell R. W. Alteration in intracellular sodium concentration and ouabain-sensitive ATPase in erythrocytes from hyperthyroid patients. J Clin Endocrinol Metab. 1976 Jun;42(6):1056–1063. doi: 10.1210/jcem-42-6-1056. [DOI] [PubMed] [Google Scholar]
  13. Dainiak N., Sutter D., Kreczko S. L-triiodothyronine augments erythropoietic growth factor release from peripheral blood and bone marrow leukocytes. Blood. 1986 Dec;68(6):1289–1297. [PubMed] [Google Scholar]
  14. Das K. C., Mukherjee M., Sarkar T. K., Dash R. J., Rastogi G. K. Erythropoiesis and erythropoietin in hypo- and hyperthyroidism. J Clin Endocrinol Metab. 1975 Feb;40(2):211–220. doi: 10.1210/jcem-40-2-211. [DOI] [PubMed] [Google Scholar]
  15. DeLuise M., Flier J. S. Status of the red cell Na,K-pump in hyper- and hypothyroidism. Metabolism. 1983 Jan;32(1):25–30. doi: 10.1016/0026-0495(83)90151-8. [DOI] [PubMed] [Google Scholar]
  16. Dintenfass L., Forbes C. D., McDougall I. R. Blood viscosity in hyperthyroid and hypothyroid patients. Haemostasis. 1974;3(5-6):348–352. doi: 10.1159/000214073. [DOI] [PubMed] [Google Scholar]
  17. Donati R. M., Warnecke M. A., Gallagher N. I. Ferrokinetics in hyperthyroidism. Ann Intern Med. 1965 Dec;63(6):945–950. doi: 10.7326/0003-4819-63-6-945. [DOI] [PubMed] [Google Scholar]
  18. Dube M. P., Davis F. B., Davis P. J., Schoenl M., Blas S. D. Effects of hyperthyroidism and hypothyroidism on human red blood cell Ca2+-ATPase activity. J Clin Endocrinol Metab. 1986 Feb;62(2):253–257. doi: 10.1210/jcem-62-2-253. [DOI] [PubMed] [Google Scholar]
  19. Eakin D. L., Peake R. L., Weiss G. B. Effect of therapy on the neutropenia of hyperthyroidism. South Med J. 1983 Mar;76(3):335-7, 340. doi: 10.1097/00007611-198303000-00017. [DOI] [PubMed] [Google Scholar]
  20. Edelman I. S. Thyroid thermogenesis. N Engl J Med. 1974 Jun 6;290(23):1303–1308. doi: 10.1056/NEJM197406062902308. [DOI] [PubMed] [Google Scholar]
  21. Feldman J. M., Roche J. Effect of hyper- and hypothyroidism on platelet monoamine oxidase activity and serotonin metabolism. Metabolism. 1977 Jun;26(6):657–664. doi: 10.1016/0026-0495(77)90087-7. [DOI] [PubMed] [Google Scholar]
  22. Flaim K. E., Li J. B., Jefferson L. S. Effects of thyroxine on protein turnover in rat skeletal muscle. Am J Physiol. 1978 Aug;235(2):E231–E236. doi: 10.1152/ajpendo.1978.235.2.E231. [DOI] [PubMed] [Google Scholar]
  23. Funakoshi S., Deutsch H. F. Human carbonic anhydrases. V. Levels in erythrocytes in various states. J Lab Clin Med. 1971 Jan;77(1):39–45. [PubMed] [Google Scholar]
  24. Gahlenbeck H., Bartels H. Veränderung der Sauerstoffbindungskurven des Blutes bei Hyperthyreosen und nach Gabe von Trijodthyronin bei Gesunden und bei Ratten. Klin Wochenschr. 1968 May 15;46(10):547–548. doi: 10.1007/BF01747774. [DOI] [PubMed] [Google Scholar]
  25. Gibson J. G., Harris A. W. CLINICAL STUDIES OF THE BLOOD VOLUME. V. HYPERTHYROIDISM AND MYXEDEMA. J Clin Invest. 1939 Jan;18(1):59–65. doi: 10.1172/JCI101026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ginsberg A. M., Clutter W. E., Shah S. D., Cryer P. E. Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte beta-adrenergic receptor density in man. J Clin Invest. 1981 Jun;67(6):1785–1791. doi: 10.1172/JCI110218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Goebel K. M., Goebel F. D., Neitzert A., Hausmann L., Schneider J. Adaptation of red cell enzymes and intermediates in metabolic disorders. Enzyme. 1975;19(4):201–211. doi: 10.1159/000458993. [DOI] [PubMed] [Google Scholar]
  28. Golde D. W., Bersch N., Chopra I. J., Cline M. J. Thyroid hormones stimulate erythropoiesis in vitro. Br J Haematol. 1977 Oct;37(2):173–177. doi: 10.1111/j.1365-2141.1977.tb06833.x. [DOI] [PubMed] [Google Scholar]
  29. Hellem A. J., Segaard E., Solem J. H. The adhesiveness of human blood platelets and thyroid function. Acta Med Scand. 1975 Jan-Feb;197(1-2):15–17. doi: 10.1111/j.0954-6820.1975.tb04871.x. [DOI] [PubMed] [Google Scholar]
  30. Herman J., Resnitzky P., Fink A. Association between thyrotoxicosis and thrombocytopenia. A case report and review of the literature. Isr J Med Sci. 1978 Apr;14(4):469–475. [PubMed] [Google Scholar]
  31. How J., Davidson R. J., Bewsher P. D. Red cell changes in hyperthyroidism. Scand J Haematol. 1979 Oct;23(4):323–328. doi: 10.1111/j.1600-0609.1979.tb02869.x. [DOI] [PubMed] [Google Scholar]
  32. Hrycek A., Kalina Z. Changes in the metabolism and functions of peripheral blood neutrophils in patients with thyroid diseases. Endokrynol Pol. 1984;35(1):45–50. [PubMed] [Google Scholar]
  33. Hymes K., Blum M., Lackner H., Karpatkin S. Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis. Ann Intern Med. 1981 Jan;94(1):27–30. doi: 10.7326/0003-4819-94-1-27. [DOI] [PubMed] [Google Scholar]
  34. Irvine W. J., Wu F. C., Urbaniak S. J., Toolis F. Peripheral blood leucocytes in thyrotoxicosis (Graves' disease) as studied by conventional light microscopy. Clin Exp Immunol. 1977 Feb;27(2):216–221. [PMC free article] [PubMed] [Google Scholar]
  35. Iwatani Y., Amino N., Mori H., Asari S., Izumiguchi Y., Kumahara Y., Miyai K. T lymphocyte subsets in autoimmune thyroid diseases and subacute thyroiditis detected with monoclonal antibodies. J Clin Endocrinol Metab. 1983 Feb;56(2):251–254. doi: 10.1210/jcem-56-2-251. [DOI] [PubMed] [Google Scholar]
  36. Jacobs P., Majoos F., Perrotta A. Hyperthyroidism and immune thrombocytopenia. Postgrad Med J. 1984 Oct;60(708):657–661. doi: 10.1136/pgmj.60.708.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kellett H. A., Sawers J. S., Boulton F. E., Cholerton S., Park B. K., Toft A. D. Problems of anticoagulation with warfarin in hyperthyroidism. Q J Med. 1986 Jan;58(225):43–51. [PubMed] [Google Scholar]
  38. Kendall A. G., Bastomsky C. H. Hemoglobin A2 in hyperthyroidism. Hemoglobin. 1981;5(6):571–577. doi: 10.3109/03630268108991688. [DOI] [PubMed] [Google Scholar]
  39. Khan F. A., Baron D. N. Ion flux and Na+,K+-ATPase activity of erythrocytes and leucocytes in thyroid disease. Clin Sci (Lond) 1987 Feb;72(2):171–179. doi: 10.1042/cs0720171. [DOI] [PubMed] [Google Scholar]
  40. Khojasteh A., Perry M. C. Thyrotoxic erythrocytosis. South Med J. 1982 Mar;75(3):379–380. doi: 10.1097/00007611-198203000-00040. [DOI] [PubMed] [Google Scholar]
  41. Kuhn J. M., Rieu M., Rochette J., Krishnamoorthy R., Labie D., Elion J., Luton J. P., Bricaire H. Influence of thyroid status on hemoglobin A2 expression. J Clin Endocrinol Metab. 1983 Aug;57(2):344–348. doi: 10.1210/jcem-57-2-344. [DOI] [PubMed] [Google Scholar]
  42. Kurasaki M., Saito T., Kaji H., Kojima Y., Saito K. Increased erythrocyte catalase activity in patients with hyperthyroidism. Horm Metab Res. 1986 Jan;18(1):56–59. doi: 10.1055/s-2007-1012225. [DOI] [PubMed] [Google Scholar]
  43. Kurata Y., Nishioeda Y., Tsubakio T., Kitani T. Thrombocytopenia in Graves' disease: effect of T3 on platelet kinetics. Acta Haematol. 1980;63(4):185–190. doi: 10.1159/000207396. [DOI] [PubMed] [Google Scholar]
  44. Lahtinen R. Sideroblasts and haemosiderin in thyrotoxicosis. Scand J Haematol. 1980 Sep;25(3):237–243. doi: 10.1111/j.1600-0609.1981.tb01395.x. [DOI] [PubMed] [Google Scholar]
  45. Lamberg B. A., Kivikangas V., Pelkonen R., Vuopio P. Thrombocytopenia and decreased life-span of thrombocytes in hyperthyroidism. Ann Clin Res. 1971 Apr;3(2):98–102. [PubMed] [Google Scholar]
  46. Laville M., Riou J. P., Bougneres P. F., Canivet B., Beylot M., Cohen R., Serusclat P., Dumontet C., Berthezene F., Mornex R. Glucose metabolism in experimental hyperthyroidism: intact in vivo sensitivity to insulin with abnormal binding and increased glucose turnover. J Clin Endocrinol Metab. 1984 Jun;58(6):960–965. doi: 10.1210/jcem-58-6-960. [DOI] [PubMed] [Google Scholar]
  47. Liechty R. D. The thyrotoxicosis/thrombocytopenia connection. Surgery. 1983 Dec;94(6):966–968. [PubMed] [Google Scholar]
  48. MULDOWNEY F. P., CROOKS J., WAYNE E. J. The total red cell mass in thyrotoxicosis and myxoedema. Clin Sci. 1957 May;16(2):309–314. [PubMed] [Google Scholar]
  49. MURPHY J. R. Erythrocyte metabolism. II. Glucose metabolism and pathways. J Lab Clin Med. 1960 Feb;55:286–302. [PubMed] [Google Scholar]
  50. Madec A. M., Allannic H., Genetet N., Gueguen M., Genetet G., Fauchet R., Stefanutti A., Orgiazzi J. T lymphocyte subsets at various stages of hyperthyroid Graves' disease: effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA status. J Clin Endocrinol Metab. 1986 Jan;62(1):117–121. doi: 10.1210/jcem-62-1-117. [DOI] [PubMed] [Google Scholar]
  51. Magid E. Determination of erythrocyte carbonic anhydrase B and C: an aid in the diagnosis of thyroid disorders? Scand J Clin Lab Invest. 1970 Nov;26(3):257–262. doi: 10.3109/00365517009046231. [DOI] [PubMed] [Google Scholar]
  52. McCLELLAN J. E., DONEGAN C., THORUP O. A., LEAVELL B. S. Survival time of the erythrocyte in myxedema and hyperthyroidism. J Lab Clin Med. 1958 Jan;51(1):91–96. [PubMed] [Google Scholar]
  53. Michels R. C., Ober K. P., Hennessy J. F. Cation transport in intact erythrocytes of hyperthyroid patients: role of the NaK-ATPase pump. Horm Metab Res. 1981 Nov;13(11):635–638. doi: 10.1055/s-2007-1019358. [DOI] [PubMed] [Google Scholar]
  54. Miller L. D., Sugarman H. J., Miller W. W., Delivoria-Papadopoulos M., Diaco J. F., Gottlieb A. J., Oski F. A. Increased peripheral oxygen delivery in thyrotoxicosis: role of red cell 2, 3-diphosphoglycerate. Ann Surg. 1970 Dec;172(6):1051–1058. doi: 10.1097/00000658-197012000-00020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Monti M., Hedner P., Ikomi-Kumm J., Valdemarsson S. Erythrocyte metabolism in hyperthyroidism: a microcalorimetric study on changes in the Embden-Meyerhof and the hexose monophosphate pathways. Acta Endocrinol (Copenh) 1987 May;115(1):87–90. [PubMed] [Google Scholar]
  56. Monti M., Hedner P., Ikomi-Kumm J., Valdemarsson S. Erythrocyte thermogenesis in hyperthyroid patients: microcalorimetric investigation of sodium/potassium pump and cell metabolism. Metabolism. 1987 Feb;36(2):155–159. doi: 10.1016/0026-0495(87)90010-2. [DOI] [PubMed] [Google Scholar]
  57. Monti M. Red cell 2,3-diphosphoglycerate in patients with hyperthyroidism before and after treatment. Acta Med Scand. 1974 Oct;196(4):263–266. doi: 10.1111/j.0954-6820.1974.tb01007.x. [DOI] [PubMed] [Google Scholar]
  58. Monti M., Wadsö I. Microcalorimetric measurements of heat production in human erythrocytes. II. Hyperthyroid patients before, during and after treatment. Acta Med Scand. 1976;200(4):301–308. [PubMed] [Google Scholar]
  59. Mori H., Amino N., Iwatani Y., Kabutomori O., Asari S., Motoi S., Miyai K., Kumahara Y. Increase of peripheral B lymphocytes in Graves' disease. Clin Exp Immunol. 1980 Oct;42(1):33–40. [PMC free article] [PubMed] [Google Scholar]
  60. Nightingale S., Vitek P. J., Himsworth R. L. The haematology of hyperthyroidism. Q J Med. 1978 Jan;47(185):35–47. [PubMed] [Google Scholar]
  61. Nishi Y., Kawate R., Usui T. Zinc metabolism in thyroid disease. Postgrad Med J. 1980 Dec;56(662):833–837. doi: 10.1136/pgmj.56.662.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Oppenheimer J. H., Schwartz H. L., Mariash C. N., Kinlaw W. B., Wong N. C., Freake H. C. Advances in our understanding of thyroid hormone action at the cellular level. Endocr Rev. 1987 Aug;8(3):288–308. doi: 10.1210/edrv-8-3-288. [DOI] [PubMed] [Google Scholar]
  63. Pangaro J. A., Weinstein M., Devetak M. C., Soto R. J. Red cell zinc and red cell zinc metalloenzymes in hyperthyroidism. Acta Endocrinol (Copenh) 1974 Aug;76(4):645–650. doi: 10.1530/acta.0.0760645. [DOI] [PubMed] [Google Scholar]
  64. Peschle C., Zanjani E. D., Gidari A. S., McLaurin W. D., Gordon A. S. Mechanism of thyroxine action on erythropoiesis. Endocrinology. 1971 Aug;89(2):609–612. doi: 10.1210/endo-89-2-609. [DOI] [PubMed] [Google Scholar]
  65. Popovic W. J., Brown J. E., Adamson J. W. The influence of thyroid hormones on in vitro erythropoiesis. Mediation by a receptor with beta adrenergic properties. J Clin Invest. 1977 Oct;60(4):907–913. doi: 10.1172/JCI108845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Ratge D., Hansel-Bessey S., Wisser H. Altered plasma catecholamines and numbers of alpha- and beta-adrenergic receptors in platelets and leucocytes in hyperthyroid patients normalized under antithyroid treatment. Acta Endocrinol (Copenh) 1985 Sep;110(1):75–82. doi: 10.1530/acta.0.1100075. [DOI] [PubMed] [Google Scholar]
  67. Reddy J., Brownlie B. E., Heaton D. C., Hamer J. W., Turner J. G. The peripheral blood picture in thyrotoxicosis. N Z Med J. 1981 Mar 11;93(679):143–145. [PubMed] [Google Scholar]
  68. Rennie J. A., Bewsher P. D., Murchison L. E., Ogston D. Coagulation and fibrinolysis in thyroid disease. Acta Haematol. 1978;59(3):171–177. doi: 10.1159/000207759. [DOI] [PubMed] [Google Scholar]
  69. Rivlin R. S., Wagner H. N., Jr Anemia in hyperthyroidism. Ann Intern Med. 1969 Mar;70(3):507–516. doi: 10.7326/0003-4819-70-3-507. [DOI] [PubMed] [Google Scholar]
  70. Rogers J. S., 2nd, Shane S. R., Jencks F. S. Factor VIII activity and thyroid function. Ann Intern Med. 1982 Nov;97(5):713–716. doi: 10.7326/0003-4819-97-5-713. [DOI] [PubMed] [Google Scholar]
  71. Rubython E. J., Cumberbatch M., Morgan D. B. Changes in the number and activity of sodium pumps in erythrocytes from patients with hyperthyroidism. Clin Sci (Lond) 1983 Apr;64(4):441–447. doi: 10.1042/cs0640441. [DOI] [PubMed] [Google Scholar]
  72. Schernthaner G., Prager R., Weissel M., Höfer R. Decreased insulin receptor binding in hyperthyroidism. Klin Wochenschr. 1984 Nov 15;62(22):1074–1080. doi: 10.1007/BF01711376. [DOI] [PubMed] [Google Scholar]
  73. Self T., Weisburst M., Wooten E., Straughn A., Oliver J. Warfarin-induced hypoprothrombinemia. Potentiation by hyperthyroidism. JAMA. 1975 Mar 17;231(11):1165–1166. [PubMed] [Google Scholar]
  74. Shenfield G. M. Influence of thyroid dysfunction on drug pharmacokinetics. Clin Pharmacokinet. 1981 Jul-Aug;6(4):275–297. doi: 10.2165/00003088-198106040-00003. [DOI] [PubMed] [Google Scholar]
  75. Simone J. V., Abildgaard C. F., Schulman I. Blood coagulation in thyroid dysfunction. N Engl J Med. 1965 Nov 11;273(20):1057–1061. doi: 10.1056/NEJM196511112732001. [DOI] [PubMed] [Google Scholar]
  76. Singh H. C., Sarkar F. H., Singh R. H., Udupa K. N. Blood platelet monoamine oxidase and acetylcholinesterase in thyrotoxicosis. Indian J Med Res. 1980 Mar;71:384–386. [PubMed] [Google Scholar]
  77. Smith E. K., Samuel P. D. Abnormalities in the sodium pump of erythrocytes from patients with hyperthyroidism. Clin Sci. 1970 Jan;38(1):49–61. doi: 10.1042/cs0380049. [DOI] [PubMed] [Google Scholar]
  78. Smith T. J., Edelman I. S. The role of sodium transport in thyroid thermogenesis. Fed Proc. 1979 Jul;38(8):2150–2153. [PubMed] [Google Scholar]
  79. Snyder L. M., Reddy W. J. Thyroid hormone control of erythrocyte 2,3-diphosphoglyceric acid concentrations. Science. 1970 Aug 28;169(3948):879–880. doi: 10.1126/science.169.3948.879. [DOI] [PubMed] [Google Scholar]
  80. Suzuki K., Fujino R. Alteration in activities of Na,K, ATPase, sugar transport, and insulin receptors in erythrocytes from hyperthyroid patients. Metabolism. 1986 Apr;35(4):371–377. doi: 10.1016/0026-0495(86)90158-7. [DOI] [PubMed] [Google Scholar]
  81. Suzuki K., Kadowaki T., Sekimizu M., Shishiba Y. Erythrocyte ouabain binding capacity as a possible cellular index of hyperthyroid status. Endocrinol Jpn. 1983 Oct;30(5):609–614. doi: 10.1507/endocrj1954.30.609. [DOI] [PubMed] [Google Scholar]
  82. Swaminathan R., Segall N. H., Chapman C., Morgan D. B. Red-blood-cell composition in thyroid disease. Lancet. 1976 Dec 25;2(8000):1382–1385. doi: 10.1016/s0140-6736(76)91920-6. [DOI] [PubMed] [Google Scholar]
  83. Sütterlin U., Gless K. H., Schaz K., Hüfner M., Schütz V., Hunstein W. Peripheral effects of thyroid hormones: alteration of intracellular Na-concentration, ouabain-sensitive Na-transport, and Na-Li countertransport in human red blood cells. Klin Wochenschr. 1984 Jun 15;62(12):598–601. doi: 10.1007/BF01728180. [DOI] [PubMed] [Google Scholar]
  84. Viherkoski M., Lamberg B. A. The glucose-6-phosphate dehydrogenase activity (G-6-PD) of the red blood cells in hyperthyroidism and hypothyroidism. Scand J Clin Lab Invest. 1970 Mar;25(2):137–143. doi: 10.3109/00365517009049195. [DOI] [PubMed] [Google Scholar]
  85. Volpé R. Immunoregulation in autoimmune thyroid disease. N Engl J Med. 1987 Jan 1;316(1):44–46. doi: 10.1056/NEJM198701013160109. [DOI] [PubMed] [Google Scholar]
  86. Weatherall D. J., McIntyre P. A. Developmental and acquired variations in erythrocyte carbonic anhydrase isozymes. Br J Haematol. 1967 Jan;13(1):106–114. doi: 10.1111/j.1365-2141.1967.tb08699.x. [DOI] [PubMed] [Google Scholar]
  87. Zaroulis C. G., Kourides I. A., Valeri C. R. Red cell 2,3-diphosphoglycerate and oxygen affinity of hemoglobin in patients with thyroid disorders. Blood. 1978 Jul;52(1):181–185. [PubMed] [Google Scholar]
  88. van Ouwerkerk B. M., Krenning E. P., Docter R., Bos G., van Oudenaren A., Benner R., Hennemann G. Cellular and humoral immunity in patients with hyperthyroid Graves' disease before, during and after antithyroid drug treatment. Clin Endocrinol (Oxf) 1987 Apr;26(4):385–394. doi: 10.1111/j.1365-2265.1987.tb00795.x. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES